Chemosensory tuft cells and intestinal homeostasis
化学感应簇细胞和肠道稳态
基本信息
- 批准号:9294307
- 负责人:
- 金额:$ 14.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-04-05 至 2017-11-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAgonistAreaBiochemicalBiologyCell CommunicationCellsCellular biologyChronicDataDetectionDevelopmentDiseaseEnterocytesEnteroendocrine CellEpithelialEpithelial CellsEpitheliumFutureGenetic TranscriptionGerm-FreeGnotobioticGoblet CellsGrantHomeostasisHypersensitivityImmuneImmune responseImmune systemImmunityImpairmentIn VitroInfectionInflammatoryInflammatory Bowel DiseasesIntestinal parasiteIntestinesKnowledgeLeadMeasuresMentorshipMicrobeMonitorMono-SMucosal ImmunityMucous body substanceMusPaneth CellsParasitesPeptidesPhysiologicalPhysiologyReactionReceptor CellReportingResearch PersonnelRibosomal RNARoleSentinelSeriesShapesSignal TransductionTaste BudsTaste PerceptionTestingTrainingantimicrobialantimicrobial peptidecell typecytokinedesignexperiencegut microbiotain vivoinsightintestinal homeostasismembermicrobialmicrobiomemicrobiotanext generation sequencingnovelnovel therapeuticsreceptorresponsesensortargeted treatment
项目摘要
Project Summary
Epithelial cells form a physical and biochemical barrier against the vast number of microbes inhabiting
the gut. Secretion of mucus and antimicrobial peptides by epithelial cells enhance barrier function and
shape the composition of the microbiota. Intestinal epithelial cells also monitor lumenal microbes and
transmit information to underlying immune cells to shape mucosal immunity. Within the collective
epithelium there are six specialized subsets of cells, including tuft cells. Previously, the function of tuft
cells was unknown until our group and two others reported their role in parasite response and
mucosal immunity. The mechanistic basis of parasite recognition by tuft cells is poorly understood, as
both the receptors and microbial agonists are unknown. To close this knowledge gap, this proposal
will build on our observation that tuft cells utilize taste-chemosensation to respond to parasite
infections. First, we will identify the taste-chemosensory receptors that detect parasites. In parallel we
determine the microbial agonists that stimulate tuft cell taste chemosensation. Using next-generation
sequencing and gnotobiotic mice, this study will disentangle the role of the parasite-altered
microbiome from direct stimulation of tuft cells by parasites and their products. This project will yield
valuable information on specific interactions between tuft cell receptors and their agonists thereby
expanding the understanding of taste receptors as novel intestinal microbial recognition receptors.
Tuft cells and taste-chemosensation are fundamentally new form of microbial detection in the gut and
represent a promising area to develop future therapies targeting intestinal inflammatory disease. In
addition the data, training, and knowledge obtained from this proposal are critical for my continued
development as an independent investigator.
项目摘要
上皮细胞形成了一个物理和生化屏障,以抵御大量的微生物栖息在
内脏上皮细胞分泌粘液和抗菌肽增强屏障功能,
塑造微生物群的组成。肠上皮细胞还监测管腔微生物,
将信息传递给潜在的免疫细胞以形成粘膜免疫。在本集体内部
上皮细胞有六个专门的细胞亚群,包括簇细胞。以前,簇绒的功能
细胞是未知的,直到我们的小组和另外两个人报告了它们在寄生虫反应中的作用,
粘膜免疫毛簇细胞识别寄生虫的机制基础知之甚少,
受体和微生物激动剂都是未知的。为了弥补这一知识差距,本提案
将建立在我们观察到的毛簇细胞利用味觉化学感受来响应寄生虫的基础上
感染.首先,我们将确定检测寄生虫的味觉化学感受器。同时,我们
确定刺激毛丛细胞味觉化学感受的微生物激动剂。使用下一代
测序和gnotobiotic小鼠,这项研究将解开寄生虫改变的作用,
寄生虫及其产物直接刺激簇细胞的微生物组。该项目将产生
有价值的信息之间的具体相互作用簇细胞受体和它们的激动剂,从而
扩大了对味觉受体作为新型肠道微生物识别受体的理解。
簇细胞和味觉化学感觉是肠道中微生物检测的基本新形式,
代表了开发针对肠道炎性疾病的未来疗法的有前途的领域。在
此外,从本提案中获得的数据、培训和知识对于我继续工作至关重要
发展成为独立调查员。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael R Howitt其他文献
Michael R Howitt的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael R Howitt', 18)}}的其他基金
Tuft cell regulation of Peyers patch composition and organization
簇细胞对派尔氏斑组成和组织的调节
- 批准号:
10640203 - 财政年份:2022
- 资助金额:
$ 14.96万 - 项目类别:
Tuft cell regulation of Peyers patch composition and organization
簇细胞对派尔氏斑组成和组织的调节
- 批准号:
10509539 - 财政年份:2022
- 资助金额:
$ 14.96万 - 项目类别:
Impact of symbiotic protists on intestinal T cell homeostasis and inflammation.
共生原生生物对肠道 T 细胞稳态和炎症的影响。
- 批准号:
10570264 - 财政年份:2021
- 资助金额:
$ 14.96万 - 项目类别:
Impact of symbiotic protists on intestinal T cell homeostasis and inflammation.
共生原生生物对肠道 T 细胞稳态和炎症的影响。
- 批准号:
10181790 - 财政年份:2021
- 资助金额:
$ 14.96万 - 项目类别:
Impact of symbiotic protists on intestinal T cell homeostasis and inflammation.
共生原生生物对肠道 T 细胞稳态和炎症的影响。
- 批准号:
10361308 - 财政年份:2021
- 资助金额:
$ 14.96万 - 项目类别:
Chemosensory tuft cells and intestinal homeostasis
化学感应簇细胞和肠道稳态
- 批准号:
9886236 - 财政年份:2017
- 资助金额:
$ 14.96万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 14.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 14.96万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 14.96万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 14.96万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 14.96万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 14.96万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 14.96万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 14.96万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 14.96万 - 项目类别:
Fentanyl Addiction: Individual Differences, Neural Circuitry, and Treatment with a GLP-1 Receptor Agonist
芬太尼成瘾:个体差异、神经回路和 GLP-1 受体激动剂治疗
- 批准号:
10534864 - 财政年份:2023
- 资助金额:
$ 14.96万 - 项目类别:














{{item.name}}会员




